Nurten Sayar, MD

The man who cracked the biology behind Ozempic still works as a hospital doctor and made almost nothing, while the drug built on his discovery became the best-selling medicine on Earth. His name is John Eng. He worked at a Veterans Affairs hospital in the Bronx, treating diabetes patients all day and running experiments on the side. No big lab. No famous university behind him. Just a hospital bench and a question that would not leave him alone. The question was about a lizard. The Gila monster is a fat, slow desert lizard from Arizona. It eats maybe three or four times a year. That is not a typo. It can go months without a single meal and its blood sugar stays perfectly stable the entire time. No spikes. No crashes. A human who ate like that would be dead or in a coma. The lizard is fine. In the early 1980s, some government researchers noticed that the venom of this lizard did something strange to the pancreas, the organ that controls blood sugar. They filed it away as a curiosity and moved on. Nobody chased it. Eng chased it. He could not exactly go catch a venomous lizard in the Bronx. So he did the only thing he could afford. He ordered dried, preserved Gila monster venom out of a mail-order catalog from a reptile supplier in Utah. It showed up in the post. He started pulling it apart to see what was inside. In 1992 he found it. A molecule nobody had ever documented, hiding in the venom. He named it exendin-4. Here is why it mattered. Your own body makes a hormone that tells your pancreas to release insulin after you eat. It is called GLP-1. It works beautifully. There is just one problem. It falls apart in about two minutes. Your body destroys it almost as fast as it makes it, which makes it useless as a medicine. Scientists knew about it and kept hitting the same wall. The lizard molecule did the exact same job. It walked up to the same door in your cells and opened it the same way. But it did not fall apart in two minutes. It kept working for hours. The lizard had evolved a version of the human hormone that survived. Nature had already solved the problem medicine was stuck on. Eng knew what he was holding. His own employer did not care. The VA refused to patent it, because a lizard diabetes drug did not count as a "veteran-specific" problem. So Eng paid for the patent himself. Out of his own pocket. A hospital doctor spending his own money to protect a discovery his bosses had shrugged at. Then he went looking for a drug company to build it. For three years, every door shut. A diabetes drug made from lizard spit sounded like a joke. Serious pharmaceutical people did not want their name on it. One scientist who watched it happen said Eng was completely frustrated, that none of the important people would even look at him. In 1996 he pinned a poster to a wall at a diabetes conference and stood next to it. Most people walked past. One researcher from a small California company called Amylin stopped and actually read it. One month later they licensed his patent. That poster became a drug called Byetta. The FDA approved it in 2005, thirteen years after Eng first pulled the molecule out of that mail-order venom. It was the first drug of its kind ever sold. A twice-a-day shot for diabetes, grown from the spit of a lizard that eats twice a year. Byetta was the proof. It showed the whole world that this pathway worked in real humans. And once everyone could see it worked, the giants moved in. A Danish company took the same idea and built a better version. Instead of copying the lizard, they modified the human hormone directly so it would survive in the body the way the lizard's did. That drug is semaglutide. You know it by its other names. Ozempic. Wegovy. So no, Ozempic is not literally lizard venom. It is built from the human hormone. But nobody would have built it if a lizard in the desert had not proven the whole idea could work first, and if one Bronx doctor had not refused to let that proof die on a shelf. In 2025 alone, that single family of drugs did over 48 billion dollars in sales. It has become the best-selling prescription medicine on the planet. Celebrities take it. Your neighbors take it. It is on every feed you scroll. People treat it like it appeared out of nowhere two years ago. It did not. The door it walks through was found in lizard venom by a hospital doctor who bought his samples by mail. Here is the part that should sit with you. John Eng got paid for Byetta, the drug built directly from his lizard molecule. But Ozempic and Wegovy, the ones worth tens of billions, were built from the human hormone instead of his exendin-4. So he does not collect a cent from the biggest drug story in the world. The man who proved the whole thing was possible watches the boom from the outside. Every person injecting themselves this week is using a door that a lizard evolved and a forgotten doctor refused to stop knocking on. The molecule was always there. The lizard had it the whole time. It just took one man who wouldn't stop asking why a monster in the desert never goes hungry.